RA

Rupa Ameet Soni

Active Director Director DIN 03018672
DIN 03018672 First appointment May 2010 Primary industry Service
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2010
Shareholding value •••• Premium profile

About Rupa Ameet Soni

Data last updated:

Rupa Ameet Soni is a Director at Excelleza Clinical Trial Solutions Private Limited (since 2010). The company operates in Service. Excelleza Clinical Trial Solutions Private Limited reported revenue of ₹13.9 Lakh (FY 2025).

DIN 03018672
Primary Designation Director
Industry Service
First Appointment 20 May 2010
Oldest Company Age 16 yrs
Largest company Excelleza Clinical Trial Solutions Private Limited · ₹13.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 May 20102010₹13.9 Lakh (FY 2025)Active

Board colleagues of Rupa Ameet Soni

Directorship timeline

Open interactive timeline →
Excelleza Clinical Trial Solutions Private Limited
Premium access

Shareholding and investment profile for Rupa Ameet Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupa Ameet Soni

Rupa Ameet Soni currently holds 1 directorship: Excelleza Clinical Trial Solutions Private Limited (Director, since 20 May 2010, revenue ₹13.9 Lakh (FY 2025)).

Rupa Ameet Soni was first appointed on 20 May 2010 as Director at Excelleza Clinical Trial Solutions Private Limited.

The current boards of Rupa Ameet Soni's companies include Kokilaben Soni (Excelleza Clinical Trial Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available